Skip to main navigation Skip to search Skip to main content

Safety of Tacrolimus in Autoimmune Disease: Results From Post-marketing Surveillance in South Korea

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
Journal대한류마티스학회지
StatePublished - 2021.10.1

Cite this